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Mechanisms affecting the implementation
of a national antimicrobial stewardship
programme; multi-professional perspectives
explained using normalisation process
theory
Kay Currie1* , Rebecca Laidlaw1ˆ, Valerie Ness1, Lucyna Gozdzielewska1, William Malcom2, Jacqueline Sneddon3,
Ronald Andrew Seaton4 and Paul Flowers1
Abstract
Background: Antimicrobial stewardship (AMS) describes activities concerned with safe-guarding antibiotics for the
future, reducing drivers for the major global public health threat of antimicrobial resistance (AMR), whereby
antibiotics are less effective in preventing and treating infections. Appropriate antibiotic prescribing is central to
AMS. Whilst previous studies have explored the effectiveness of specific AMS interventions, largely from uni-
professional perspectives, our literature search could not find any existing evidence evaluating the processes of
implementing an integrated national AMS programme from multi-professional perspectives.
Methods: This study sought to explain mechanisms affecting the implementation of a national antimicrobial
stewardship programme, from multi-professional perspectives. Data collection involved in-depth qualitative
telephone interviews with 27 implementation lead clinicians from 14/15 Scottish Health Boards and 15 focus
groups with doctors, nurses and clinical pharmacists (n = 72) from five Health Boards, purposively selected for
reported prescribing variation. Data was first thematically analysed, barriers and enablers were then categorised, and
Normalisation Process Theory (NPT) was used as an interpretive lens to explain mechanisms affecting the
implementation process. Analysis addressed the NPT questions ‘which group of actors have which problems, in which
domains, and what sort of problems impact on the normalisation of AMS into everyday hospital practice’.
Results: Results indicated that major barriers relate to organisational context and resource availability. AMS had
coherence for implementation leads and prescribing doctors; less so for consultants and nurses who may not
access training. Conflicting priorities made obtaining buy-in from some consultants difficult; limited role perceptions
meant few nurses or clinical pharmacists engaged with AMS. Collective individual and team action to implement
AMS could be constrained by lack of medical continuity and hierarchical relationships. Reflexive monitoring based
on audit results was limited by the capacity of AMS Leads to provide direct feedback to practitioners.
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Conclusions: This study provides original evidence of barriers and enablers to the implementation of a national
AMS programme, from multi-professional, multi-organisational perspectives. The use of a robust theoretical
framework (NPT) added methodological rigour to the findings. Our results are of international significance to
healthcare policy makers and practitioners seeking to strengthen the sustainable implementation of hospital AMS
programmes in comparable contexts.
Keywords: Antimicrobial stewardship programme, Multi-professional perspectives, Qualitative research,
Normalisation process theory
Contributions to the literature
 Many studies have explored influences on
individuals’ antibiotic prescribing behaviour or
evaluated the effectiveness of specific interventions
intended to improve prescribing; the impact of
implementation efforts on the sustainability of
interventions in an organisational context is not well
known.
 This study looked beyond measured effectiveness of
specific interventions, towards understanding the
mechanisms by which these interventions can be
accepted, adopted, and routinely embedded in
clinical practice.
 Our findings contribute to filling a gap in the
evidence by explaining the factors that act as
barriers or enablers to the processes of
implementing and sustaining improved prescribing
in a complex, multi-professional setting.
Background
The growing resistance of an increasing number of or-
ganisms to antimicrobial drugs used to prevent or treat
infection has been characterised as a major threat to
public health and “a threat to global stability and na-
tional security” [1](p.1), challenging the future delivery
of modern medicine as we know it [2–4]. A variety of
drivers to antimicrobial resistance (AMR) have been
proposed, with inappropriate use of antibiotics recog-
nised as a significant factor [1, 5]. Antimicrobial stew-
ardship (AMS) can be defined as “making the best use of
antimicrobials to manage infection so as to ensure opti-
mal outcomes and minimal harm to patients and the
wider society” [6] or “a coherent set of actions which
promote using antimicrobials responsibly” [7](p.793).
AMS is a key component of global strategies to combat
AMR [1, 8]. These global strategies have been translated
into local interventions via national AMS programmes
[9, 10]. In Scotland, this led to the introduction of an
Antimicrobial Management Team (AMT) in each re-
gional Health Board, led by a medical infection specialist
and an AMS pharmacist [11]. The work of the AMTs is
co-ordinated nationally by the Scottish Antimicrobial
Prescribing Group (SAPG), who collaborate with local
teams to develop, disseminate and monitor the impact
of strategies and guidelines to improve prescribing qual-
ity. The AMS programme in this study was established
to deliver the first Scottish Action Plan in 2008 [11] and
our evaluation follows ten years of evolving
implementation.
The effectiveness of AMS interventions in changing
prescribing behaviour and impacting on associated clin-
ical outcomes has been reported in several studies. A re-
cent systematic review [12] highlighted the potential
impact of in-patient AMS programmes in significantly
reducing the incidence of a range of antibiotic resistant
organisms, an important clinical outcome. An updated
Cochrane review [13], reported that targeted interven-
tions to improve antibiotic prescribing to hospital in-
patients are effective in increasing compliance with anti-
biotic policy and reducing duration of antibiotic treat-
ment, thereby influencing key drivers to AMR. The
review also concluded that future research should be di-
rected towards exploring the barriers and enablers to the
implementation of interventions. Furthermore, the sus-
tainability of AMS interventions is not clear from the
existing evidence.
There is a body of evidence examining factors influen-
cing the prescribing behaviours of doctors, such as lack
of guideline knowledge, time constraints, risk aversion,
patient pressure, and social norms [14–16]. However,
there is more limited evidence of specific barriers and
enablers to the implementation of AMS programmes in
the hospital setting [17, 18]. To our knowledge, no pre-
vious studies have systematically investigated multi-
professional factors associated with implementing a na-
tionally agreed AMS programme within the acute hos-
pital setting, across multiple health regions.
The use of theoretical frameworks from the social sci-
ences can aid exploration of implementation challenges
in complex situations. For instance, Normalisation
Process Theory (NPT) [19–21] has been used extensively
to evaluate implementation processes and to aid inter-
pretation and explanation of barriers and facilitators
within health care research [22]. The core constructs of
NPT relate to the properties of the intervention
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(capability of working and being integrated in practice)
and the contribution practitioners make via the mecha-
nisms of coherence, cognitive participation, collective ac-
tion, and reflexive monitoring [23] (explained below).
NPT also acknowledges the influence of the context of
practice, whereby “organisational setting, complex intra-
and inter-professional interactions, multiple competing
tasks operationalised under pressure” come into play
[24] p.291. These factors impact on the individual and
teams’ ability to introduce and sustain new practices.
The aim of this paper is to explain the mechanisms in-
fluencing implementation of a national programme for
AMS in acute-care hospitals across Scotland, using NPT
as an interpretive framework to explore multi-
professional perspectives. By applying NPT, we address
the questions ‘which group of actors’ (e.g. AMTs, doc-
tors, nurses, clinical pharmacists) ‘have which problems’,
and ‘what sort of problems are these’?
Methods
This exploratory qualitative study used in-depth tele-
phone interviews with AMS implementers (AMT lead
infection specialist consultants, AMT pharmacists, AMT
nurses) from 14 out of a possible 15 regional Health
Boards (one board did not have an AMT), and 15 local
focus groups with front-line hospital practitioners (pre-
scribing doctors, ward based nurses, and clinical phar-
macists) from five purposively selected Health Boards.
Criteria for selection of Health Boards as focus group
sites was based on documented variation in specific anti-
biotic use (high or low volume) recorded in the national
Hospitals Medicines Utilisation Database (which collects
information from hospital pharmacy systems and pre-
sents standardised information on medicines usage).
Access for the study was provided by the Research &
Development department in each participating Health
Board. Approval for the study was granted by the Glasgow
Caledonian University School of Health & Life Sciences
Ethics Committee (HLS/NCH/17/020). The SAPG
Programme Lead acted as a gatekeeper to AMTs in each
Health Board, circulating study information to all AMT
members, who then contacted the research team to ar-
range participation. AMT members in the Health Boards
that were selected for focus group participation circulated
study information to potential participants via posters,
email, group meetings, or individual contact; those practi-
tioners who were available and interested then attended
planned focus groups at each health board site. All partici-
pants were provided with study information prior to vol-
untary participation and each confirmed written consent.
Interview and focus group topic guides were devel-
oped, with broad question areas related to participant’s
role or experience related to AMS, perceptions of bar-
riers and enablers to AMS, recommendations to
strengthen AMS (Additional file 1). These topic guides
were used flexibly to enable in-depth probing of partici-
pant responses. Interviews and focus groups were con-
ducted April–July 2018, by experienced researchers (KC,
RL, VN), not previously known to participants, and were
digitally recorded and fully transcribed before being
imported into NVivo 11©software for data management.
Interviews and focus groups lasted between 24 and 72
min, averaging 50 min.
May and colleagues [20] indicate the various ways in
which NPT can be used to analyse and interpret data;
we adopted the recommendation to conduct a standard
inductive thematic analysis then structured our inter-
pretation by reframing the themes around NPT con-
structs, addressing the NPT questions outlined above.
Data was analyzed in three stages: firstly, transcripts
were inductively coded using Braun & Clark’s [25] prin-
ciples of thematic analysis; secondly, a content analysis
approach [26] was used to extract, condense and cat-
egorise (according to already identified themes) a list of
factors which acted as barriers or enablers to AMS; fi-
nally, NPT was used to explain the properties of the
intervention and mechanisms of action which help or
hinder the routinisation of AMS into everyday clinical
practice. The research was funded as part of a
programme of work intended to inform policy; none of
the researchers had prior bias or assumptions related to
the research topic. Rigour in data analysis was achieved
by maintaining an audit trail of coding via NVivo© and
peer review of all coding and category development by
at least two researchers (KC, RL, VN), with agreement in
analytical decisions reached during team discussions.
COREQ reporting criteria for qualitative research were
applied [27].
Results
Participant numbers per occupational category are
shown in Table 1. All Scottish AMT pharmacists partici-
pated (n = 15) and nine out of a possible 14 AMT med-
ical leads were interviewed (five were unable to
participate due to workload pressures). All three AMT
nurses in-post were interviewed. Front-line practitioners
from each included profession participated in discipline
specific focus groups at each of the five purposively se-
lected Health Boards i.e. three focus groups per Health
Board, five groups per discipline (3–9 per group, n = 72).
A total of 99 individuals participated overall.
Thematic analysis of the full data set identified six key
themes influential in the implementation of AMS:
‘people matter’; ‘context, time and resources matter’;
‘knowledge experience and confidence matters’; ‘priori-
tisation matters’; ‘technology matters’; and ‘feedback
matters’. Detailed categorisation of all barriers and en-
ablers is available in Additional file 2.
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Operationalising NPT within the study
The following sections apply the lens of NPT to explain
the properties of the intervention (capability), contextual
elements, and mechanisms of action affecting the imple-
mentation of AMS in hospital settings. Participant
quotes are referenced by interview or focus group num-
ber and professional category (e.g. Interview1 Doctor).
Table 2 below maps each theme to the respective NPT
component, with a brief explanation of the construct
provided at the beginning of each result section.
Capability: how ‘workable’ is the AMS programme?
The multi-level Scottish AMS programme is described
in ScotMARAP which outlines the responsibilities of
various groups, including SAPG, Health Boards, the
AMTs, and antibiotic prescribers [11]. The end-goal of
the programme is compliance with SAPG evidence
based AMS guidelines. In general, medical staff are fa-
miliar with a guideline based approach to prescribing, al-
though a degree of professional autonomy in decision
making is normally accepted.
The SAPG AMS guidelines [28] begin by recommending
which type, dose, and mode of administration of antibiotic
is indicated; this action would normally be undertaken at
the point of initial patient assessment and management by
the attending doctor. This aspect of the guideline is inher-
ently ‘workable’, as prescribing treatment is an essential part
of normal care and any change in practice required relates
mainly to the specific antibiotic to be used. However, subse-
quent components of the guidelines (i.e. recording indica-
tion for antibiotic, recommended review of antibiotic at 72
h, switch from intravenous to oral antibiotic, limited dur-
ation of antibiotic) all require additional action to be taken,
sometimes at a later stage, potentially by different practi-
tioners from the original prescriber and involving more
senior staff who influence decision making. Thus, compo-
nents of the theme ‘people matter’, may challenge the
‘workability’ of some aspects of the guidelines.
Context
‘Context’ refers to the ways in which resource and task
allocation, social roles, and team norms in the areas in
Table 1 Participant numbers per occupational category
Occupational category Number
AMT Lead Infection Specialist Consultant 9
AMT Pharmacist (1 per 13 boards, 2 from one large board) 15
AMT Nurses (few boards have AMS nurses) 3
Total AMT participants across 14 NHS Health Boards 27
Prescribing doctors × 5 focus groups (3–6 participants per focus group) 21
Clinical pharmacists × 5 focus groups (3–9 participants per focus group) 28
Ward based nurses × 5 focus groups (4–6 participants per focus group) 23
Total front-line practitioner participants across 5 NHS Health Boards 72
Total study participants 99
Table 2 Mapping of themes to relevant NPT constructs
Theme NPT Constructs
People matter:
(leadership, relationships, staff buy-in, staff continuity)





Knowledge, experience & confidence matters:





(relative prioritisation given to AMS in relation to competing objectives)
• Cognitive participation
Context, time and resources matter:
(size and complexity of the organisation, availability of staff, time)




(methods of accessing information & communicating; presence or absence of meaningful data)
• Collective action
Feedback matters:
(the nature and timing of feedback on audit data)
• Reflexive monitoring
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which AMS is to be integrated are negotiated [21]. Of
particular interest here is the level of discretion which
those involved in AMS implementation have over re-
sources (normative restructuring) and their own and
others’ actions (relational restructuring).
Our analysis indicated that a major challenge to the im-
plementation of the AMS programme relates to available
resource, which impacts on many of the mechanisms de-
tailed below. This begins with the staff resource available
to the AMT, which influences all subsequent implementa-
tion actions. In NPT terms, opportunities for normative
restructuring, or modifying resource allocation, are con-
strained; thematically, ‘context, time and resources matter’.
Similarly, hierarchical relationships within teams (Doctors
Vs Consultants, Nurses Vs Doctors) may impact on pre-
scribing decision making, with collective action to imple-
ment AMS being affected. Opportunities for relational
restructuring, i.e. reframing roles and responsibilities, may
be limited; ‘people matter’ here.
Coherence: how do participants make sense of AMS?
The construct of coherence encapsulates the work indi-
viduals and groups do to make sense of a new practice,
in this case understanding the principles of the AMS
programme. It relates to the ways individuals and teams
understand the purpose of AMS, recognise the differ-
ences between this new way of working and previous
practice, understand what is required of them, and
thereby construct the potential value of AMS to their
work. The themes ‘people matter’ and ‘knowledge, ex-
perience and confidence matters’ were influential here.
Coherence was enabled by the strategic work of the
national SAPG network, carried forward in each Health
Board by the AMT. SAPG brings together a multi-
disciplinary group of key stakeholders with an interest in
implementing AMS, including representation from all
Scottish Health Boards. AMT interviews highlight the
value of SAPG in co-ordinating national efforts; enabling
networking and sharing of experiences and solutions;
generating consensus; and providing an authoritative
voice to support local implementation:
“I find it very helpful. I mean, it’s good especially
when you’re one person leading the AMT here and
trying to further this agenda, to have a national body
behind you saying, look, this is what everyone in
Scotland is doing, this is what’s appropriate, this is
what everyone else thinks is correct, and if you want
to have a variance from it then we need to have a
pretty good reason behind it. It’s really useful to have
that authority behind you.” [Interview4, Doctor]
AMT participants were clear that the national ap-
proach afforded by SAPG enabled a collective sense of
purpose and value for AMS work. However, translation
of this potential into everyday clinical practice requires
that front-line practitioners involved in prescribing and
administering antimicrobials are also aware of, and can
see the value of, AMS.
Raising awareness of AMS is a key function of AMTs.
This was enabled across all Health Boards during the in-
duction of new junior doctors and by the availability of
local prescribing guidelines. In general, AMT members
believed that junior doctors readily accessed local pre-
scribing guidelines and were diligent in using these:
“The willingness of our junior doctors to come on
board with things has been really useful … they tend
to listen to what is local guidance and policy and they
will follow our guidelines really well. So I’ve been
quite impressed with them.” [Interview19 Doctor]
However, raising awareness of AMS policies with more
established medical staff, or those who were transient,
such as locum consultants, was more problematic:
“we don’t really have good conversations with the
consultants. … The junior doctors tend to follow
guidelines very well. However, we know that they
defer to their seniors for decisions about antibiotic
treatment. So if we’re not having much linkage with
registrars, specialist registrars and consultants to
update them in stewardship messages and the rea-
sons why…” [Interview5 Pharmacist]
Similarly, whilst some AMTs were engaged in targeted
AMS training activities with nurses, education for nurs-
ing staff was generally recognised as being insufficient.
“I think enabling nurses to be released from the
wards is challenging. The staffing levels are perhaps
so low, the acuity within the wards is so high, that
nurses probably aren’t getting the chance to come
out for 30 minutes to an hour from clinical time.”
[Interview10 Nurse]
This view was supported by many nursing focus
group participants. Whilst some nurses reported men-
tion of antibiotic use during intravenous therapy
training, and some were aware of the NHS Education
for Scotland (NES) AMS workbook for nurses, most
reported limited awareness of stewardship or the
nurse’s role therein.
“I think because it's (AMS) something that has never
been discussed as part of my role, I've never ever
thought well...questioned myself about it” [FG4
Nurses]
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Some examples of excellent work to raise awareness and
engage with nurses around AMS were provided, how-
ever these were generally a result of targeted projects in
a limited number of wards, and were not commonly part
of AMT activity in most Boards. Thus, for many, lack of
time and resource to engage with nursing staff created a
significant barrier to raising awareness of AMS for
nurses and challenged their ability to make sense of the
issues.
Findings indicated that SAPG and AMTs have clarity
around the purpose, value, and demands of AMS. In
general, junior doctors in all Boards have well-
established opportunities to understand the require-
ments of AMS via induction training and the accessibil-
ity of guidelines – AMS has coherence for them.
Conversely, problems of coherence lie primarily in rela-
tion to limited accessibility or uptake of AMS informa-
tion for other practitioner groups, across all Boards.
Cognitive participation: how is ‘buy-in’ to AMS achieved?
The construct of cognitive participation relates to the
work that goes on at various structural levels to secure
the consent, co-operation and ongoing support of other
players. The themes ‘people matter’ and ‘prioritisation
matters’ are influential in this construct; despite ener-
getic leadership by AMTs, competing priorities may
serve to undermine support for AMS.
Effective leadership by AMT lead consultants and
AMT pharmacists is fundamental to the initiation and
legitimisation of AMS. Engaging with and directly influ-
encing others seems core to their success.
“I think my predecessor is the reason why it (AMS)
works so well…. she is able to make sure that people
who would never come to AMT, like an ortho-
paedic surgeon, comes every single time and doesn’t
feel like he’s being dragged there kicking and
screaming.” [Interview19 Doctor]
Conversely, lack of leadership influence was noted to
inhibit AMT effectiveness, with restrictions on commit-
ment or capacity mentioned by some:
“there's been a bit more kind of difficulty, I suppose,
in getting someone to lead the AMT. I think people
have been more sort of cajoled into doing it some-
times … that's been a bit of a stumbling block”
[Interview14 Pharmacist]
In addition, the importance of buy-in and clinical lead-
ership from medical consultants was highlighted; AMT
participants particularly noted the influential role that
senior medical consultants have on junior doctors:
“…and if they’re (consultants) enthusiastic, then that
trickles down through the rest of the team. So if
they see the consultant going to the guidelines and
seeing what it is they should have patients on …
they then realise that that’s what’s expected of
them.” [Interview23 Pharmacist]
However, most AMT participants noted variation in
the commitment and buy-in from different medical spe-
cialties, with some evidence of a general pattern across
different regional boards:
“I think it’s very variable, part of that relates to spe-
cialty. So we’ve got a bigger buy-in from the medical
consultants than we do from the surgical. Now, we
have buy-in from the orthopaedics, but the general
surgeons, they are… we’ve struggled to get engage-
ment with them. And because we’ve not got a buy-
in from the consultants, we’ve not got the buy-in
from their junior staff.” [Interview21 Doctor]
Opportunities for nurses to engage in AMS were lim-
ited in most boards. A variety of reasons were offered by
participants for lack of nurse enrolment in AMS, ranging
from nurses ‘lacking confidence’, feeling disempowered,
to nurse managers seeing AMS as the work of prescrib-
ing doctors and not a task they wanted staff to take on
as a nursing role.
“when we’ve tried to engage nurses in IVOST
(switching from intravenous to oral antibiotics),
sometimes it’s worked, but … when I’ve asked them
why (they don’t), they said that they don’t feel
empowered to do it. They say the doctors don’t lis-
ten to them.” [Interview1 Pharmacist]
“Any conversations I’ve had with them (nurse man-
agers), some are more supportive than others; but,
to be honest, I think they’re just so ‘trying to man
the wards’, they’re just so kind of ‘let’s just keep our
head above water’ that anything in addition to that
is a sort of an extra ask almost.” [Interview8
Pharmacist]
For AMT participants, AMS was a clear priority, how-
ever, not all stakeholders attributed the same importance
to AMS. In some medical specialities, the needs of their
patient group were viewed as ‘different’ and obtaining
buy-in to AMS guidelines was challenging:
“… haematologists, I think in that area there is a
practice that everybody must get everything (antibi-
otics) because there’s so much to lose, and that’s
coloured by experience…. I hear haematologists talk
about people developing septic complications of
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chemotherapy and dying rapidly with multi-drug re-
sistant bugs and then that is translated into, well,
we have to treat everybody who has an infection
with this sort of blunderbuss therapy.” [Interview2
Doctor]
For others, the multitude of competing priorities gen-
erated a barrier to prioritising AMS:
“We compete with lots of different initiatives at lots
of different times, so for example, it’s the national
sepsis day or something, and sepsis is very import-
ant … but, our experience is that the management
of sepsis tends to mean that more people get given
antibiotics almost on a ‘just in case basis’ … so it’s
an issue between us, that that (sepsis six) almost
promotes additional antibiotic use when we’re try-
ing to stop inappropriate antibiotic use” [Interview4
Pharmacist]
The work of cognitive participation was neatly
summed up by this participant:
“I think the biggest thing is making it part of every-
one’s job, everyone’s life, as opposed to just being
designated to the chosen few that happen to have it
as their job …. I think that’s the biggest message we
need to sell is that everyone has a role to play in
stewardship and it’s not just the antibiotic pharma-
cist and the micro guys.” [Interview23 Pharmacist]
Overall, whilst AMTs and most junior doctors were
committed to the principles of AMS, some challenges
remain in selling the importance of the AMS message to
specific groups of medical consultants. Similarly, re-
source constraints or role definitions limited efforts to
enlist nurses in AMS. The ‘sepsis six’ care bundle initia-
tive also presented a barrier to the prioritisation of ap-
propriate prescribing messages. However, where there is
effective and energetic AMT leadership engaging widely
with relevant stakeholders, endorsed by other medical
consultants and opinion leaders, participants readily
agree that AMS should be part of their work and sup-
port the use of AMS guidelines.
Collective action: what do people do to enact AMS
guidelines?
Collective action refers to work undertaken by individ-
uals and groups, at different structural levels, to enact
the practices associated with AMS. It requires the organ-
isational context to be appropriately supportive; for indi-
viduals to have the necessary skills and to perform the
tasks associated with AMS; and for different stake-
holders to trust in the AMS related work carried out by
others. Fundamentally, this construct answers the ques-
tion ‘how does the work of AMS get done?’ Once again,
the theme ‘people matter’ is important, here the barriers
presented by lack of medical staff continuity is promin-
ent. ‘Knowledge, experience & confidence’ is also influen-
tial, often with the interpersonal dimension of having
confidence to apply knowledge in team-based interac-
tions being key. Hierarchical relationships within med-
ical teams often impacts on the prescribing behaviours
of more junior doctors.
The ability of these factors to impede effective AMS
actions are illustrated in the quote below.
“so you get told on a ward round to start these
things and then you look at their swab samples then
you think, that doesn’t make any sense from what
we’re told in our app (AMS guidelines). So you then
phone micro and micro say, ‘no, no, no, do that’
and you change it, and the consultant gets annoyed
the next day or you’re not there on the ward round
because you’ve gone off shift and you go back a
week later and they’ve been put back on the old an-
tibiotics.” [FG2 Doctors]
Nurse participation in AMS varied, and whilst there
were examples of nurses working in specialist roles be-
ing actively involved in stewardship conversations, a
more typical description of the limited involvement of
nurses in stewardship is offered below:
“I’m just at ward level giving out the antibiotics that
are prescribed.” [FG14 nurses]
Nurses’ confidence to challenge doctors in poten-
tially hierarchical relationships also varied:
“It depends on what experience you’ve got. There
are some doctors who do not take kindly to being
reminded of those things. Whereas others are very
approachable and will listen to you. Some will ig-
nore you just to prove a point.” [FG14 Nurses]
Challenges in ‘context, time and resources’ often cre-
ate significant barriers to collective action, primarily
via restrictions on staff resource and therefore time
available for the different component activities of
AMS. Whilst these challenges affect all staff groups,
the capacity for clinical pharmacists to engage in
AMS at ward level varied markedly across Health
Boards: some incorporate AMS activity in their nor-
mal work, including reviewing all prescription charts
and discussing issues related to antimicrobial pre-
scriptions with clinical staff; others visit wards only to
manage discharge prescriptions and have very little
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involvement in routine management of other
prescriptions:
“Well, from the moment a patient is admitted,
they're looking for their discharge moment, not day,
their moment. And that takes priority over every-
thing else. You can be quite involved in really quite
serious clinical work, but you will have flow coordi-
nators, and other such people, looking over your
shoulder telling you, you should be doing the pre-
scription because they want that patient out. That’s
all they care about.” [FG8 Pharmacists]
The physical environment was also influential, and re-
lated to this, ‘technology’, or lack thereof, can either sup-
port or hamper AMS work, as shown below:
“there are a number of issues. One is time, so now
we’ve moved to our new hospital, their ward rounds
are taking longer, physically taking longer to do …
part of that relates to the layout of the wards and
part of it relates to IT issues, so we’ve gone to a
hospital that’s all single rooms and they’re having to
log into computers in each single room. We have an
electronic prescribing system, so they’re having to
log in each time to review the electronic prescribing
system, to review antibiotics [that takes additional
time] so they essentially are not doing that in a
timely way on the ward rounds.” [Interview21
Doctor)
Therefore, a variety of factors may enable, but often
constrain, the ability of different practitioners to collect-
ively work towards delivering the AMS programme.
Reflexive monitoring: what do people do to appraise the
consequences of their contribution to AMS?
This construct relates to the work participants are in-
volved in when trying to understand and evaluate a
complex intervention such as AMS in practice. By moni-
toring practice, areas for improvement become apparent
and further support can be offered. This relates directly
to the theme ‘feedback matters’. Whilst AMTs in all
Health Boards undertook monthly audits of prescribing
indicators, reported to SAPG and collated nationally,
there is an evident dichotomy in activities thereafter.
Some AMTs ensured direct, point-of-care feedback to
practitioners, for example
“when we go to the ward to collect the data we
would always let the staff know, the medics and the
nursing staff, that we have arrived on the ward and
we’re doing this audit; and then once we’ve finished
the audit, we’ll give the senior charge nurse a verbal
feedback as to how the ward has done, whether that
be good or bad, and we would also let the medics
know this is what we’ve found and you’re either
doing great, carry on, or we’ve found a couple of
things a wee bit wrong, can you just ….” [Interview9
Pharmacist]
Others do not provide any direct feedback and there-
fore practitioners are not aware of their AMS perform-
ance compliance and have little opportunity to improve
prescribing quality:
“so we have collected a huge amount of data over
the last wee while through (audit of) prescribing in-
dicators. But I don’t think we’d used it, so we col-
lected the data … but we hadn’t shared it with the
clinical teams that were from where we had col-
lected it.” [Interview12 Physician]
“I've never had any feedback. I am aware that the
audit is happening, but I've never had any feedback.”
[FG3 Doctors]
Similarly, whilst a few AMTs use audit data to target
quality improvement projects, most report no capacity
for quality improvement work and therefore opportun-
ities for the reflexive component of monitoring are lost.
“I have to say I don’t think all the audit programme
is necessarily as useful as it could be. I think we col-
lect a lot of data and we don’t have the capacity to
do the QI improvement work that should be done
alongside it; that’s my bugbear about it.” [Interview7
Pharmacist]
Our findings suggested significant variation in the level
of passive or active feedback of prescribing data to front
line prescribers, with some exemplary practice con-
trasted with resource constraints limiting direct feedback
and quality improvement opportunities.
Summary of findings
The previous analysis detailed the properties/workability
of the AMS intervention and the mechanisms of action
across each specific NPT construct. Using NPT can then
reframe interpretation of data to address the questions
‘which group of actors have which problems, and what
sort of problems are these? Based on the preceding ana-
lysis of activity within each NPT construct, Table 3 pro-
vides a summary response to those questions.
Discussion
To our knowledge, this is the first study to investigate
the implementation of a national AMS programme from
a multi-level, multi-professional perspective, using NPT
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to explain challenges in the process of implementation.
A further strength is the sampling strategy, enabling in-
clusion of AMT implementers from all Scottish Health
Boards and groups of front-line doctors, nurses and clin-
ical pharmacists from five diverse Health Boards. The
relatively large sample size (n = 99) for a qualitative
study, the diverse geographical distribution of partici-
pants, and the multi-professional nature of the data
gathered means we are confident that sufficient data
with ‘information power’ was generated to reflect the na-
ture of the phenomenon [29]. We believe these findings
are transferable to similar health care contexts inter-
nationally, although we make no claims regarding gener-
alisability of the results. In particular, we recognise the
potential limitation of self-selection of focus group par-
ticipants, albeit their employing health boards were pur-
posively sampled.
In considering the work done to implement AMS, this
discussion focuses on the multi-professional groups of
‘actors’ involved and the typical challenges they faced.
The role of SAPG nationally and AMTs at Health Board
level provided an implementation approach with signifi-
cant potential to impact on prescribing behaviours by
engaging, informing, advising, monitoring, and providing
feedback to front-line practitioners. This study identified
many examples of excellent AMT practice in all these
areas, however, variation in the resource allocation, lead-
ership capability, and the nature of the specific activities
undertaken by AMTs in each Health Board means that
there remains significant scope for AMT potential to be
further realised. As discussed by Huttner and colleagues
[30] in a narrative review of AMS success stories from
around the world, sharing obstacles and success stories
in implementing AMS programmes enables the global
stewardship community to benefit from the experience
of others. Our study provides one such exemplar, using
NPT to explain those mechanisms which help and hin-
dered implementation in the Scottish acute care context.
Our evidence suggests that for most medical practi-
tioners, AMS guidelines have inherent workability and
coherence: in NPT terms, they are differentiated from
previous antibiotic prescribing practice; individuals and
teams agree the purpose of AMS; the availability of
guidelines means that participants understand what is
required of them; and the approaches to AMS are valued
as part of prescribing work. However, working patterns
often led to a lack of continuity in medical staff involve-
ment in patient care. This could fracture the workability
of AMS beyond initial prescribing, with key aspects ‘fall-
ing between the gaps’, particularly in relation to review
Table 3 Summary of analysis
Actors Capability Context Coherence Cognitive
participation
Collective action Reflexive monitoring
AMT Limitations on
organisational support
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and role priorities which
limit opportunities for
AMS related activities.
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of antibiotic use. This difficulty has been recognised
elsewhere and additional mechanisms to trigger review
have been advocated [31, 32].
Particular tensions were found in our study between
AMS principles and heightened concerns around sepsis.
Broom and colleagues [33] also found that perceived im-
mediate clinical risks for individuals tend to dominate
doctor’s prescribing decisions over longer term population
health risk. Greater challenges were reported in engaging
some consultant level doctors, particularly in surgical, re-
spiratory and haematology where AMS may not be priori-
tised due to perceived specialist patient needs. Consultant
preferences, which may conflict with AMS guidelines,
were found to be influential on junior doctor prescribing
actions. Likewise, Broom and colleagues [16] who argued
for a sociological understanding of antibiotic misuse in
the hospital sector, found doctors’ experiences of interper-
sonal and intra-professional pressures, and the role of
localised norms, influenced prescribing behaviours. The
potential contextual barrier of medical hierarchies and
role expectations was also described by Charani and asso-
ciates [34], who highlighted the role of ‘prescribing eti-
quette’ in determining the cultural rules within medical
prescribing practice. As consultants present a powerful so-
cial influence on the behaviour of doctors in training, their
engagement in AMS is an area for ongoing attention.
With some isolated exceptions, we found the contribu-
tion of nurses in promoting AMS was under-utilised,
with dominant role expectations and resource con-
straints presenting contextual barriers to participation.
Limited opportunities for training meant that nurses
were often not aware of their potential contribution to
AMS; for nurses, the AMS process lacked coherence
therefore potential cognitive participation and collective
action were severely constrained. There is growing dis-
cussion in the literature advocating greater nurse in-
volvement in AMS [35–37], with other exploratory
studies finding comparable results to ours [38–40]; how-
ever, intervention studies which detail approaches to
strengthen the nurse’s role are limited [41, 42]. As
nurses are the most consistently present members of the
healthcare workforce, capitalising on the continuity
afforded by nurses to prompt prescribers, who are more
likely to be transient, would be of significant benefit in
strengthening AMS.
Whilst the specialist AMT pharmacist was acknowl-
edged as fundamental to the success of AMS pro-
grammes, the capacity for other clinical pharmacists to
engage in AMS at ward level varied markedly across
Health Boards. The idea of AMS was coherent for them
and participants reported wishing to be more involved,
however they were largely impeded in collective action
by challenging contextual factors such as resource allo-
cation for the various components of their role, with an
emphasis on discharge planning to the detriment of other
elements. Time constraints were also reported by Weier
and colleagues [43], in a cross-sectional survey of Austra-
lian and French hospital pharmacists (n = 259). Similarly,
the need for protected time for stewardship within a sup-
portive organisational culture was highlighted in a small
qualitative study of pharmacists in the USA’s Veterans Af-
fairs centres [44]. The potential for the wider clinical
pharmacist workforce to engage more directly with pre-
scribers than is possible for the specialist AMT pharmacist
may be worthy of further consideration.
The benefits and challenges of providing effective feed-
back on prescribing indicator audit to enable reflexive
monitoring were highlighted across participant groups.
The potential impact of audit and feedback in changing
professional behaviour is well-recognised, with the con-
clusions from Ivers and colleagues’ 2012 Cochrane re-
view being relevant here [45]. However, resource
constraints affected AMTs’ ability to provide active feed-
back to prescribers in many regional Boards.
Underpinning many of the implementation challenges
for individual actors outlined above, organisational con-
text, particularly staff resource and availability of relevant
technology to support working practices, were highlighted
as exerting an influence on AMS implementation. Atten-
tion to these contextual components is required to gain
maximum traction in improving AMS further.
Conclusions
Our study highlighted the beneficial impact of a national
approach towards AMS, with strategic leadership rolled
out at local level. Findings have illustrated key enablers
and important barriers to the implementation of AMS,
examined through the lens of NPT.
Future attention should be directed towards the organisa-
tional context and resource requirements for AMS imple-
mentation. Developing AMT leadership skills, as well as
practitioner confidence and knowledge via accessible edu-
cation, and capitalising on the potential contribution of
nurses should be considered. Technological solutions, such
as electronic prescribing and other systems which provide
behavioural prompts, in addition to feedback mechanisms
to reinforce positive change, are recommended.
This study has important implications internationally
for others seeking to implement AMS in the hospital
setting. There is evidence from international studies [12,
13] that AMS interventions can have beneficial impact
on appropriate antibiotic prescribing and reductions in
antibiotic resistant infections. The challenge for health-
care providers is to maximise the impact of such inter-
ventions by focusing on implementation processes
which enable the sustainable integration of AMS into
routine practice.
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